- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
TRJ
ASX
Week ended 09 Oct 2026
Weekly Investor Report
Trajan Group Holdings Limited · Healthcare · Medical Instruments & Supplies
Latest close
0.285 AUD
21.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -0.2% below the Trend Line and sits at 19.4% of its 52-week range. The latest completed week returned 21.3%, after a 83.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100.
Setup score
39
out of 100
Latest Close
0.285 AUD
9 Oct 2026
1W Return
21.3%
latest completed week
4W Return
83.9%
short-term follow-through
12W Return
16.3%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 37.59% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
21.3%
Latest completed week; four-week move 83.9%.
Indicator stack
0/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 37.59%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -0.2% below the Trend Line and sits at 19.4% of its 52-week range. The latest completed week returned 21.3%, after a 83.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
18 Sep
25 Sep
2 Oct
9 Oct
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1412-week average 0.17
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 83.9% over four weeks, 16.3% over 12 weeks, and -63.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.16Latest activity-pressure read.
Pressure change600.7%Four-week change in activity pressure.
Leadership-35.64Latest relative-leadership reading.
RS change47.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.
Factor week 09 Oct 2026
Financial statements through 30 Jun 2026
Field coverage 88%
Model confidence 86%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength3/100Blend of value, momentum, and quality. Underlying universe rank 98; rank 1 is best.
Value15/100Relative valuation strength. Underlying universe rank 86; rank 1 is best.
Quality6/100Profitability and accounting quality. Underlying universe rank 95; rank 1 is best.
Momentum2/100Medium-term price momentum. Underlying universe rank 99; rank 1 is best.
Growth11/100Revenue and earnings growth. Underlying universe rank 90; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework13/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.3x Market value relative to trailing revenue.
- EV / EBITDA
- 9.9x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -3.6% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 38.4% Gross profit retained from each unit of revenue.
- Operating margin
- 1.9% Operating profit retained from revenue.
- Free-cash-flow margin
- -2.0% Free cash flow generated from revenue.
- Return on invested capital
- 1.6% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -3.1% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -147.1% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 5.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-67.1%Distance below the 52-week high.
13-week volatility15.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
17 Apr
15 May
12 Jun
10 Jul
7 Aug
4 Sep
9 Oct
Weeks higher9 of 2617 weeks finished lower.
Best week+40.0%Week of 3 Jul.
Worst week-24.5%Week of 26 Jun.
Latest week+21.3%Week of 9 Oct.
Shape of recent returns
Strong gains6
Modest gains3
Flat weeks0
Modest losses4
Sharp losses13
Recent vol15.4%13-week weekly-return volatility.
Base vol11.8%52-week weekly-return volatility.
Up/down split18/33Count of positive and negative weeks in the 52-week window.
Average skew10.6% / -7.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAU Healthcare
4-week rank1 / 100
Group average-4.5%
Trend breadth33.0%
Trend33.0%active weekly trend signals
MD62.0%positive activity pressure
RS27.0%positive relative leadership
Four-week leaders
IndustryAU Medical Instruments & Supplies
4-week rank1 / 7
Group average12.4%
Trend breadth42.9%
Trend42.9%active weekly trend signals
MD85.7%positive activity pressure
RS28.6%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape30/100
Trend, activity pressure, participation, and risk combine to a 30/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.14; No reversal markers Next-Week ExpectancyNegative 37.59%Next-week expectancy is negative with a 37.59% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors5/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 83; Buyback Yield rank 63; Small Cap Core rank 25 SVQF13/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 228.5 of 262 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
Trajan Group Holdings CEO Presents FY26 Results and Business Overview at Sharewise Webinar Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 9 Oct 2026 | 0.285 AUD | 21.3% | 0.2855 AUD | 0.8213 AUD | 1.16 | -35.64 | 584.0K | Off |
| 2 Oct 2026 | 0.235 AUD | -9.6% | 0.2915 AUD | 0.8278 AUD | 0.81 | -47.78 | 436.2K | Off |
| 25 Sep 2026 | 0.26 AUD | 36.8% | 0.3003 AUD | 0.8337 AUD | 0.36 | -43.32 | 755.5K | Off |
| 18 Sep 2026 | 0.19 AUD | 22.6% | 0.3097 AUD | 0.8394 AUD | 0.01 | -59.68 | 423.0K | Off |
| 11 Sep 2026 | 0.155 AUD | -8.8% | 0.324 AUD | 0.8456 AUD | -0.23 | -67.87 | 2.7M | Off |
| 4 Sep 2026 | 0.17 AUD | 3.0% | 0.3403 AUD | 0.8533 AUD | -0.34 | -66.61 | 79.9K | Off |
| 28 Aug 2026 | 0.165 AUD | -8.3% | 0.3572 AUD | 0.8609 AUD | -0.36 | -68.70 | 599.1K | Off |
| 21 Aug 2026 | 0.18 AUD | -5.3% | 0.3728 AUD | 0.8693 AUD | -0.52 | -66.66 | 28.1K | Off |
| 14 Aug 2026 | 0.19 AUD | -2.6% | 0.3888 AUD | 0.8791 AUD | -0.53 | -65.95 | 275.9K | Off |
| 7 Aug 2026 | 0.195 AUD | -4.9% | 0.406 AUD | 0.8891 AUD | -0.55 | -66.49 | 46.3K | Off |
| 31 Jul 2026 | 0.205 AUD | -2.4% | 0.423 AUD | 0.8999 AUD | -0.42 | -64.57 | 109.8K | Off |
| 24 Jul 2026 | 0.21 AUD | -14.3% | 0.4393 AUD | 0.9107 AUD | -0.29 | -63.57 | 6.6K | Off |
| 17 Jul 2026 | 0.245 AUD | -15.5% | 0.4548 AUD | 0.9212 AUD | -0.24 | -58.41 | 0 | Off |
| 10 Jul 2026 | 0.29 AUD | 3.6% | 0.469 AUD | 0.9312 AUD | -0.33 | -51.62 | 1.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.